🚀 VC round data is live in beta, check it out!
Nolato Valuation Multiples
Discover revenue and EBITDA valuation multiples for Nolato and similar public comparables like Oxford Nanopore Technologies, UFP Technologies, Haier Biomedical, Pulse Biosciences and more.
Nolato Overview
About Nolato
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into three segments based on end market: Medical, which develops complex product systems, components, and packaging solutions for pharmaceuticals and supplements; Integrated, which develops subsystems for mobile phones; and Industrial, which develops systems for the automotive, hygiene, packaging, and furniture industries. Roughly a third of the firm's revenue is generated in the Rest of Europe.
Founded
1938
HQ
Employees
5.8K
Website
Sectors
Financials (LTM)
EV
$2B
Nolato Financials
Nolato reported last 12-month revenue of $1B and EBITDA of $179M.
In the same LTM period, Nolato generated $193M in gross profit, $179M in EBITDA, and $87M in net income.
Revenue (LTM)
Nolato P&L
In the most recent fiscal year, Nolato reported revenue of $1B and EBITDA of $178M.
Nolato expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $193M | XXX | $189M | XXX | XXX | XXX |
| Gross Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA | $179M | XXX | $178M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $87M | XXX | $86M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | — | — | $83M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Nolato Stock Performance
Nolato has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Nolato's stock price is $5.84.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.3% | XXX | XXX | XXX | $0.32 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNolato Valuation Multiples
Nolato trades at 1.6x EV/Revenue multiple, and 9.4x EV/EBITDA.
EV / Revenue (LTM)
Nolato Financial Valuation Multiples
As of April 20, 2026, Nolato has market cap of $2B and EV of $2B.
Equity research analysts estimate Nolato's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nolato has a P/E ratio of 18.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 9.4x | XXX | 9.5x | XXX | XXX | XXX |
| EV/EBIT | 14.7x | XXX | 14.9x | XXX | XXX | XXX |
| EV/Gross Profit | 8.7x | XXX | 8.9x | XXX | XXX | XXX |
| P/E | 18.1x | XXX | 18.3x | XXX | XXX | XXX |
| EV/FCF | 31.5x | XXX | 35.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nolato Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Nolato Margins & Growth Rates
Nolato's revenue in the last 12 month grew by 4%.
Nolato's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Nolato's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nolato's rule of X is 25% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Nolato Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 3% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 25% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 5% | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 8% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Nolato Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Nolato | XXX | XXX | XXX | XXX | XXX | XXX |
| Oxford Nanopore Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| UFP Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Haier Biomedical | XXX | XXX | XXX | XXX | XXX | XXX |
| Pulse Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Oculis Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nolato M&A Activity
Nolato acquired XXX companies to date.
Last acquisition by Nolato was on XXXXXXXX, XXXXX. Nolato acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Nolato
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNolato Investment Activity
Nolato invested in XXX companies to date.
Nolato made its latest investment on XXXXXXXX, XXXXX. Nolato invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Nolato
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nolato
| When was Nolato founded? | Nolato was founded in 1938. |
| Where is Nolato headquartered? | Nolato is headquartered in Sweden. |
| How many employees does Nolato have? | As of today, Nolato has over 5K employees. |
| Who is the CEO of Nolato? | Nolato's CEO is Christer Wahlquist. |
| Is Nolato publicly listed? | Yes, Nolato is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Nolato? | Nolato trades under NOLA B ticker. |
| When did Nolato go public? | Nolato went public in 1984. |
| Who are competitors of Nolato? | Nolato main competitors are Oxford Nanopore Technologies, UFP Technologies, Haier Biomedical, Pulse Biosciences. |
| What is the current market cap of Nolato? | Nolato's current market cap is $2B. |
| What is the current revenue of Nolato? | Nolato's last 12 months revenue is $1B. |
| What is the current revenue growth of Nolato? | Nolato revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Nolato? | Current revenue multiple of Nolato is 1.6x. |
| Is Nolato profitable? | Yes, Nolato is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Nolato? | Nolato's last 12 months EBITDA is $179M. |
| What is Nolato's EBITDA margin? | Nolato's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Nolato? | Current EBITDA multiple of Nolato is 9.4x. |
| What is the current FCF of Nolato? | Nolato's last 12 months FCF is $53M. |
| What is Nolato's FCF margin? | Nolato's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Nolato? | Current FCF multiple of Nolato is 31.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.